[CLDX] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- 0.68%
YoY- -21.36%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 3,924 2,220 1,026 1,101 980 3,113 2,363 8.81%
PBT -31,563 -29,598 -31,980 -28,082 -23,140 -15,027 -11,334 18.59%
Tax -5,200 -790 -782 -2,260 -142 -105 -288 61.89%
NP -26,363 -29,598 -31,980 -28,082 -23,140 -15,027 -11,772 14.36%
Tax Rate - - - - - - - -
Total Cost 30,287 31,818 33,006 29,183 24,120 18,140 14,135 13.52%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin -671.84 -1,333.24 -3,116.96 -2,550.59 -2,361.22 -482.72 -498.18 5.10%
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS -3.05 -4.41 -4.87 -4.71 -4.28 -3.79 -4.00 -4.41%
EPS Diluted -3.05 -4.41 -4.87 -4.71 -4.28 -3.79 -4.00 -4.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.